Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 79249423Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2024
Linked Award Amount
$1.4M
Full award amounts, FY2024
Award Records
1
Records listing this PI
Award-Linked Rank
#9,355
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Charles Dimmler Iii as a PI. Multi-PI records show the full award amount for context.
- 75N93023C00015-P00003-9999-1N01DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE$1.4Maward amount
Award organization
Organizations that administered FY2024 awards listing Charles Dimmler Iii as a PI.
FY2024 award administered by Ceramedix Holding, LLC (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardCeramedix Holding, LLC
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #9355
- 2025$2M Cumulative Funding